Doxil (doxorubicin HCl liposome injection)
Published: Oct 15, 2008 8:00 am
| Brand Name: | Doxil | |
| Generic Name: | doxorubicin HCl liposome injection | |
| Code Name: | ||
| Company: | Ortho Biotech | |
| FDA Clinical Phase: | 1,2, & 3 |
Description:
Doxil is a form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxil is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma in patients whose disease has not gotten better after treatment with other anticancer drugs. It may be used together with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Doxil is a type of anthracycline antitumor antibiotic.
Clinical Trials:
For a list of clinical trials studying Doxil for the treatment of multiple myeloma, see ClinicalTrials.gov.
Official website for Doxil: http://www.doxil.com/
Source: NCI Cancer Glossary, Doxil, http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=doxil (as of September 4, 2008)
Related Articles:
- Common Measures Of Heart And Blood Vessel Health May Predict Risk Of Heart-Related Side Effects During Treatment With Kyprolis
- Nelfinavir Shows Only Limited Success In Overcoming Revlimid Resistance In Multiple Myeloma Patients
- Getting To Know: Tiragolumab
- Two Darzalex Clinical Trials Halted; Little Impact Expected On Drug’s Use In Multiple Myeloma
- Nelfinavir-Velcade Combination Very Active In Advanced, Velcade-Resistant Multiple Myeloma
